← Back to Clinical Trials
Recruiting NCT06409962

A New Technological Intervention to Address Childhood Obesity:

Trial Parameters

Condition Body Weight
Sponsor Universidad de Córdoba
Study Type INTERVENTIONAL
Phase N/A
Enrollment 215
Sex ALL
Min Age 6 Years
Max Age 16 Years
Start Date 2024-05-30
Completion 2026-12-12
Interventions
Technological combination

Brief Summary

Childhood obesity is a global public health issue, with rising prevalence rates. In Spain, the problem is significant, particularly in the southern regions. Factors contributing to childhood obesity include dietary habits, lack of physical activity, and socioeconomic influences. Efforts to address childhood obesity in Spain include various programs focusing on dietary modification, increased physical activity, and family involvement. Despite these initiatives, there is a need for continued intervention, as changing dietary and lifestyle patterns have led to reduced fruit and vegetable consumption and increased sedentary behavior among children. Childhood obesity has concerning health implications, including heart-related issues. Echocardiography plays a vital role in early detection. Given the limited research on the impact of childhood obesity on musculoskeletal development and mobility, a comprehensive study is needed to analyze its prevalence and associated factors. The study aims to assess the effectiveness of nutritional interventions administered by school nurses. In summary, childhood obesity in Spain is a growing concern, with multifaceted causes and health implications. Ongoing efforts are required to combat this issue and promote healthier lifestyles among children.

Eligibility Criteria

Inclusion Criteria: * Students from the school * Pediatric from age 6 to 16 * Students from the school that confirmed approval * Signed informed consent by the minor * Signed informed consent by the minor's parents or guardians. Exclusion Criteria: * Presence of HbA1c levels below 5.7% * Presence of HbA1c levels above 6.4% * Presence of pathological metabolic diseases, such as diabetes or metabolic syndrome * Presence of other diseases related to intestinal integrity or skin issues. * Lack of the signed informed consent by the minor and legal guardian

Related Trials